Compare XENE & MRCY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | XENE | MRCY |
|---|---|---|
| Founded | 1996 | 1981 |
| Country | Canada | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | |
| Sector | Health Care | |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.3B | 5.1B |
| IPO Year | 2014 | 1997 |
| Metric | XENE | MRCY |
|---|---|---|
| Price | $57.66 | $79.24 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 11 | 8 |
| Target Price | $68.55 | ★ $80.00 |
| AVG Volume (30 Days) | ★ 800.0K | 403.6K |
| Earning Date | 05-08-2026 | 05-05-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 72.69 |
| EPS | N/A | ★ N/A |
| Revenue | $311,000.00 | ★ $912,020,000.00 |
| Revenue This Year | N/A | $6.59 |
| Revenue Next Year | $2,496.48 | $9.56 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 9.19 |
| 52 Week Low | $28.19 | $44.01 |
| 52 Week High | $62.91 | $103.81 |
| Indicator | XENE | MRCY |
|---|---|---|
| Relative Strength Index (RSI) | 57.77 | 48.84 |
| Support Level | $39.93 | $71.79 |
| Resistance Level | $59.71 | $79.27 |
| Average True Range (ATR) | 1.90 | 3.45 |
| MACD | -0.28 | -0.22 |
| Stochastic Oscillator | 66.29 | 39.70 |
Xenon Pharmaceuticals Inc is a neuroscience-focused biopharmaceutical company committed to improving the lives of people living with neurological and psychiatric disorders. It is advancing a novel product pipeline to address areas of high unmet medical need, including epilepsy and depression. The product candidates of the group include XEN1101, NBI-921352, and XEN496 for Epilepsy and Nav1.7 oral inhibitors for Pain.
Mercury Systems Inc is a commercial technology company serving the aerospace and defense industry. The company envisions, creates, and delivers secure open architecture solutions powering a broad range of mission-critical applications in challenging and demanding environments. Its Mercury Processing Platform spans the full breadth of signal processing from radio frequency front end to the human-machine interface to convert meaningful data, gathered in remote and hostile environments, into critical decisions. The company manufactures components, products, modules, and subsystems and sells to defense prime contractors, the U.S. government, original equipment manufacturers, and commercial aerospace companies. Geographically, it derives maximum revenue from the United States.